Home

intern tidak stabil Populer flipi2 score follicular lymphoma calculator Tautan Mudah terjadi meluncurkan

Follicular lymphoma international prognostic Index (FLIPI 1 and FLIPI 2) |  Download Table
Follicular lymphoma international prognostic Index (FLIPI 1 and FLIPI 2) | Download Table

Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De  Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy

Integration of gene mutations in risk prognostication for patients  receiving first-line immunochemotherapy for follicular lymphoma: a  retrospective analysis of a prospective clinical trial and validation in a  population-based registry - The Lancet
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry - The Lancet

Workshop With the Experts: Overcoming Barriers to Optimal Treatment of Non-Hodgkin's  Lymphoma Jointly sponsored by Annenberg Center for Health Sciences. - ppt  download
Workshop With the Experts: Overcoming Barriers to Optimal Treatment of Non-Hodgkin's Lymphoma Jointly sponsored by Annenberg Center for Health Sciences. - ppt download

A simplified scoring system in de novo follicular lymphoma treated  initially with immunochemotherapy - ScienceDirect
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect

Outcome Comparisons, Stratified by FLIPI Score | Download Table
Outcome Comparisons, Stratified by FLIPI Score | Download Table

Treatment and Risk-Stratification for High-Risk Follicular Lymphoma -  Hematology Advisor
Treatment and Risk-Stratification for High-Risk Follicular Lymphoma - Hematology Advisor

Frontiers | The prognostic nutritional index, an independent predictor of  overall survival for newly diagnosed follicular lymphoma in China
Frontiers | The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China

Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De  Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy

Enhancement of the Follicular Lymphoma International Prognostic Index  (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and  histologic transformation | Blood Cancer Journal
Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation | Blood Cancer Journal

M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line  rituximab chemo‐free therapy - Lockmer - 2020 - British Journal of  Haematology - Wiley Online Library
M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line rituximab chemo‐free therapy - Lockmer - 2020 - British Journal of Haematology - Wiley Online Library

FLIPI and PRIMA-PI risk factors | Download Scientific Diagram
FLIPI and PRIMA-PI risk factors | Download Scientific Diagram

Updates in Follicular Lymphoma (Transcript)
Updates in Follicular Lymphoma (Transcript)

PFS and OS based on FLIPI and FLIPI2 | Download Table
PFS and OS based on FLIPI and FLIPI2 | Download Table

Follicular — HaemBase
Follicular — HaemBase

Clinical and Biological Prognostic Factors in Follicular Lymphoma -  Hematology/Oncology Clinics
Clinical and Biological Prognostic Factors in Follicular Lymphoma - Hematology/Oncology Clinics

Diagnostics | Free Full-Text | Imaging of Early Response to Predict  Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma  with Iodine-131-Rituximab Radioimmunotherapy
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy

Validation, revision and extension of the Follicular Lymphoma International  Prognostic Index (FLIPI) in a population-based setting - Annals of Oncology
Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting - Annals of Oncology

M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line  rituximab chemo‐free therapy - Lockmer - 2020 - British Journal of  Haematology - Wiley Online Library
M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line rituximab chemo‐free therapy - Lockmer - 2020 - British Journal of Haematology - Wiley Online Library

Prognosis and Treatment of Follicular Lymphoma
Prognosis and Treatment of Follicular Lymphoma

FLIPI2 | Mike's Chemotherapy for Follicular Cancer Experience
FLIPI2 | Mike's Chemotherapy for Follicular Cancer Experience

Real-life disease monitoring in follicular lymphoma patients using liquid  biopsy ultra-deep sequencing and PET/CT | Leukemia
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT | Leukemia

Diagnostics | Free Full-Text | Imaging of Early Response to Predict  Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma  with Iodine-131-Rituximab Radioimmunotherapy
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy

Impact of treatment in long-term survival patients with follicular lymphoma:  A Spanish Lymphoma Oncology Group registry | PLOS ONE
Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry | PLOS ONE

Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic  model that is superior to existing risk scores for predicting  progression‐free survival and early treatment failure after frontline  immunochemotherapy - Mir - 2020 -
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy - Mir - 2020 -